NCT03493256View on ClinicalTrials.gov

Novel BIochemical Markers for Predicting Type 2 NEurological Complications of Surgical Coronary Revascularization (BINER)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

March 1, 2019

Conditions
Neurological Complication of Procedure (Disorder)
Interventions
OTHER

exposure to type 2 neurological complications

exposure to postoperative cognitive dysfunction (POCD) or postoperative delirium (POD), or both concurrently.

Trial Locations (1)

85-094

Department of Cardiac Surgery, Dr Antoni Jurasz Memorial University Hospital, Bydgoszcz

All Listed Sponsors
lead

Collegium Medicum w Bydgoszczy

OTHER

NCT03493256 - Novel BIochemical Markers for Predicting Type 2 NEurological Complications of Surgical Coronary Revascularization (BINER) | Biotech Hunter | Biotech Hunter